Fulcrum Therapeutics, Inc. earnings per share and revenue

FULC earnings per share for the last quarter are -0.40 USD whereas the estimation was -0.43 USD which accounts for 6.04% surprise. Företagets omsättning för samma period uppgår till 871.00 k USD trots den uppskattade siffran 552.72 k USD. Estimated earnings per share for the next quarter are -0.44 USD, and revenue is expected to reach 416.67 k USD. Also watch annual changes over time to get a bigger picture of FULC earnings per share and revenue dynamics.